首页> 外文OA文献 >Plasmacytoma-like post-transplant lymphoproliferative disorder, a rare subtype of monomorphic B-cell post-transplant lymphoproliferation, is associated with a favorable outcome in localized as well as in advanced disease: a prospective analysis of 8 cases
【2h】

Plasmacytoma-like post-transplant lymphoproliferative disorder, a rare subtype of monomorphic B-cell post-transplant lymphoproliferation, is associated with a favorable outcome in localized as well as in advanced disease: a prospective analysis of 8 cases

机译:浆细胞样移植后淋巴增生性疾病,一种罕见的单形B细胞移植后淋巴增生的亚型,在局部和晚期疾病中均具有良好的预后:8例病例的前瞻性分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Post-transplantation lymphoproliferative disorder (PTLD) with plasmacellular differentiation has been reported as a rare subtype of monomorphic B-cell post-transplant lympho-proliferation with histological and immunophenotypical features of plasmacytoma in the non-transplant population. Here we present clinical, laboratory and histopathological features, treatment and outcome of 8 patients from the German prospective PTLD registry. Clinically, extranodal manifestations were common while osteolytic lesions were rare and none of the patients had bone marrow involvement. Immunohistochemistry showed light chain restriction and expression of CD138 without CD20 expression in all samples. An association with Epstein-Barr virus was found in 3 out of 8 cases. We suggest that the Ann Arbor classification is most useful for this disease entity and report a generally good response to treatment including reduction of immuno-suppression, surgery and irradiation in localized disease and systemic chemotherapy analogous to plasmacell myeloma in advanced disease.
机译:据报道,具有浆细胞分化的移植后淋巴细胞增生性疾病(PTLD)是一种罕见的单态B细胞移植后淋巴细胞增生的亚型,在非移植人群中具有浆细胞瘤的组织学和免疫表型特征。在这里,我们介绍了来自德国前瞻性PTLD注册中心的8例患者的临床,实验室和组织病理学特征,治疗和结局。临床上,结外表现很常见,而溶骨性病变很少,而且没有患者受累于骨髓。免疫组织化学显示在所有样品中轻链限制和CD138表达而无CD20表达。在八分之三的病例中发现了与爱泼斯坦-巴尔病毒的关联。我们建议,Ann Arbor分类对于该疾病实体最有用,并报告对治疗的总体反应良好,包括局部疾病中免疫抑制的降低,手术和放疗的减少以及类似于晚期疾病中浆细胞骨髓瘤的全身化疗。

著录项

相似文献

  • 外文文献
  • 中文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号